Sphynx cat

The Sphynx is the cat the internet cannot stop arguing about. Hairless but not quite (fine down on the nose, ears, tail and feet is normal, and the skin feels like warm suede). Egyptian in name but Canadian by every document. Marketed as hypoallergenic while its own registry admits no study backs that. And carrying both the fancy's most permissive color standard and its most contested health genetics. Almost everything interesting about this breed comes with a label, and this profile keeps the labels on.

The origin story is unusually well documented, and it starts with a kitten named Prune, born hairless in Toronto in 1966. TICA's history names the resemblance to an Egyptian sphinx sculpture as the source of the name; CFA's account agrees on Toronto and 1966. The breed's second founding thread, natural mutations in Minnesota and Toronto in the mid-to-late 1970s, is where the registries' own documents part company.

TICA's PDF counts three cats, CFA's breed page two, CFA's own magazine four. So this site states each registry's account as its own rather than averaging a head count. CFA registered the breed in 1970s-era experiments, granted championship in 2002. TICA carried it from its own founding. GCCF refused the breed in 1990, saw the UK club form in 1991, and granted recognition in 2006.

The look is a study in reading color without fur. Pigment sits in the skin itself, so a black Sphynx is a charcoal-skinned cat and a tabby may keep only ghost markings on its legs. Every registry admits every color (the colors guide maps the system), and none awards points for it. TICA's own judging material concedes hairless colors are hard enough to call that DNA testing is recommended. That is why the black Sphynx, the most-searched color by a factor of nine, sometimes turns out to be a very dark blue on paper.

On temperament, the registry voice and the measured voice tell compatible halves. The registries sell an extrovert: attention-seeking, "overly-affectionate", a therapy-cat natural (TICA's claim, attributed, uncited). The measured half is quieter and arguably better. In the 8,000-cat Finnish behaviour survey, the 272 Sphynx rows report aggression toward family, strangers and other cats at or near zero, sensitivity below average, and exactly one statistically distinct trait, licking, which is grooming, not neurosis. The famous "dog-like" framing has never been tested in a published study; the low-aggression numbers have.

Health is where this profile earns its keep, because the popular version is wrong in a dangerous direction. A 2021 study did associate a gene (ALMS1) with Sphynx heart disease. Three larger follow-up studies then failed to replicate it as predictive: in the biggest, carriers and non-carriers developed HCM at the same rate, the variant sat in over half the sampled population, and the consortium's own conclusion recommends routine gene testing only for the Maine Coon's and Ragdoll's separate MYBPC3 mutations. No laboratory offers a Sphynx HCM test.

So a breeder claiming a "DNA-tested heart-healthy" Sphynx is selling paperwork that does not exist: real screening is an echocardiogram read by a cardiologist, repeated, because a New Zealand cohort watched prevalence rise from 22 to 40 percent between scans. The COLQ myopathy test, by contrast, is real and validated; ask for both parents' results. Two eye conditions carry genuine statistical weight (corneal sequestrum at eight times the odds of other cats, entropion at four, both diagnosed years younger). And a movement disorder, paroxysmal dyskinesia, is so far documented only in this breed.

Buying one is its own research project: the price guide carries named catteries in four markets, the eye-color premium, and the rule that the crosses stacked above the Sphynx (Elf, Bambino, Dwelf) cost more while holding no registry status, which the hairless breeds roundup untangles gene by gene. The welfare question deserves its plain answer. No law in the US, UK, Canada or Australia restricts breeding or owning a Sphynx.

The Netherlands now bans both breeding and, since January 2026, acquiring one, naming the breed in the regulator's own guidance: the strongest government-sourced welfare signal in our research, and honest context for a buyer anywhere. And the allergy page starts from the sentence the marketing never quotes: TICA's own admission that no scientific studies back the low-allergen claim.